| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2007 | CN101023927A Stable eye lotion containing latanoprost as active ingredient |
| 08/29/2007 | CN101023926A 植入材料 Implant material |
| 08/29/2007 | CN101023925A Anti-cancer composition containing chemical-therapy synergistic agent |
| 08/29/2007 | CN101023921A Anti-cancer composition containing glucocorticoid hormone |
| 08/29/2007 | CN101023918A Anti-cancer medicine composition carried with platinum-like compounds and glucocorticoid hormone |
| 08/29/2007 | CN101023893A Endoluminal device for treating disease of aneurysm and combination of drugs |
| 08/29/2007 | CN100334448C Drug screening system using tetinol X receptor as target spot |
| 08/29/2007 | CN100334228C Cimeric immunomodulatory compounds and methods of using the same |
| 08/29/2007 | CN100334107C Ligands |
| 08/29/2007 | CN100334104C Triterpene derivatives and remedies for liver diseases |
| 08/29/2007 | CN100334094C Antitumoral analogs |
| 08/29/2007 | CN100334093C Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/29/2007 | CN100334091C Degraded triterpenes and their production method and use |
| 08/29/2007 | CN100334088C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 08/29/2007 | CN100334087C Method for the production of riboflavin of modification B/C in granular form |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/29/2007 | CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands |
| 08/29/2007 | CN100334049C Lung cavity aeration liquid and its preparation method |
| 08/29/2007 | CN100333804C Sodium hyaluronate anti-adhesion film, and its prepn. method |
| 08/29/2007 | CN100333798C Naloxone eye drops |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333765C Medicinal and food dual purpose oral liquid with henan region famous drug as raw materials |
| 08/29/2007 | CN100333762C Externally used medicine for curing acute or chronic soft tissue injury and process for preparing the same |
| 08/29/2007 | CN100333750C Chinese medicinal preparation for treating obstruction in chest and heart palpitation and its preparation process |
| 08/29/2007 | CN100333743C Hemorrhoid treating medicine |
| 08/29/2007 | CN100333741C Medicine for preventing and treating diabets and kidney disease and preparing method |
| 08/29/2007 | CN100333740C Tincture for trenting fungus dermatosis |
| 08/29/2007 | CN100333739C External sterilizing Mongolian medicine lotion for skin and external genital organs |
| 08/29/2007 | CN100333732C Dahurian rhododendron leaf extract and extracting method thereof |
| 08/29/2007 | CN100333731C Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
| 08/29/2007 | CN100333730C Intravenous injection of antitumor compound nobilisideA and monoacetylated liposome and its prepn. |
| 08/29/2007 | CN100333729C Breviscapine permeation pump control release preparation |
| 08/29/2007 | CN100333728C Compound electrolytic fructose injection |
| 08/29/2007 | CN100333727C Budesonide target-direction microball and preparation thereof |
| 08/29/2007 | CN100333726C Disintegration piece taken through oral cavity containing Gimeracil and Oteracil Potassium with fluorine being added |
| 08/29/2007 | CN100333725C New usage of STI-571 in application for treating acute leukaemia in marrow M2b type |
| 08/29/2007 | CN100333724C Lomefloxacin eye gel |
| 08/29/2007 | CN100333723C Iontophoretic delivery of rotigotine for the treatment of parkinson's disease |
| 08/29/2007 | CN100333722C Stable oil-in-water emulsion of propyl gallate for vein and its preparing method |
| 08/29/2007 | CN100333721C Levodopa nano preparation and its preparing method |
| 08/29/2007 | CN100333720C Compound analgesic agent |
| 08/29/2007 | CN100333717C Oral solid dosage of plus color to Rome salts |
| 08/29/2007 | CN100333715C Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 08/29/2007 | CN100333712C Material gradient controlled-release administrating system and its three-dimensional printing-forming preparation method |
| 08/29/2007 | CN100333709C Antioxidant, skin preparation for external use, cosmetic and food |
| 08/29/2007 | CN100333651C Method for purifying melatomin in milk product and detection method therefor |
| 08/28/2007 | USRE39800 One dose of 2-halodeoxyadenosine such as cladribine is given intravenously before coronary intervention, another is given intravenously after intervention and the remaining doses are given subcutaneously at weekly intervals over a subsequent period |
| 08/28/2007 | US7262317 Elastase inhibitor; respiratory system disorders; hypotensive agents; administering by injection |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262300 New crystalline monohydrates and crystalline anhydrates of gaboxadol; suitable for oral dosage administration |
| 08/28/2007 | US7262298 4-hydroxybenzomorphans |
| 08/28/2007 | US7262297 For lowering blood glucose |
| 08/28/2007 | US7262296 Substituted aryl alkenoic acid heterocyclic amides |
| 08/28/2007 | US7262292 Oligonucleotides and methods for detecting hepatitis B viral nucleic acids |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262285 Anticancer biangeloyl saponins |
| 08/28/2007 | US7262267 Polypeptide mediating cell permeability |
| 08/28/2007 | US7262224 Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof |
| 08/28/2007 | US7262223 Alkyl bis(phenylamidines); Alzheimer's disease, Down's syndrome, Mild Cognitive Impairment, age-related macular degeneration, and cerebral amyloid angiopathy |
| 08/28/2007 | US7262222 Industrial water treatment; papermaking; nitrogen-containing compounds: 1-(3-chloroallyl)-3,5,7-triaza-1-azonia-adamantane chloride, dodcylguanadine hydrochloride; aldehydes: glutaraldehyde, formaldehyde; klebsiella; pseudomonas |
| 08/28/2007 | US7262221 Hydrophobic core coupled to plurality of hydrophilic moieties that form micelles in solution; encapsulate lipoproteins; atherosclerosis; cardiovascular disorders |
| 08/28/2007 | US7262220 Antidiabetic agents |
| 08/28/2007 | US7262219 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/28/2007 | US7262218 Polymorphic forms are suitable for use as active substances of pharmaceutical dosage forms for reduction of serum cholesterol levels in the bloodstream |
| 08/28/2007 | US7262217 Use of such combinations as a preservative system, used in skincare or cosmetic products |
| 08/28/2007 | US7262216 Benzofuran compounds and their use as antidepressants and anxiolytics |
| 08/28/2007 | US7262215 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors |
| 08/28/2007 | US7262214 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases |
| 08/28/2007 | US7262213 Administering (-)-(2S,4S)-1-(2-Hydroxymethyl-1,3-dioxolan-4-yl)cytosine (also referred to as (-)-OddC) for therapy of cancer such as non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, ovarian cancer, leukemia, CNS cancer, melanoma, renal cancer, and lymphoma cancer |
| 08/28/2007 | US7262212 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/28/2007 | US7262210 Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 08/28/2007 | US7262209 Carbonyloxy-cyanomethyl compounds as antiparasitic agents |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke |
| 08/28/2007 | US7262205 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/28/2007 | US7262204 Modulation of CCR4 function |
| 08/28/2007 | US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts |
| 08/28/2007 | US7262202 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe. |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262200 Indazolinone compositions useful as kinase inhibitors |
| 08/28/2007 | US7262199 Tyrosine kinase inhibitors |
| 08/28/2007 | US7262198 Substituted heterocyclic compounds |
| 08/28/2007 | US7262197 For therapy and prophylaxis of disease or condition in a subject which disease or condition is affected by phospholipase modulation such as restenosis |
| 08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/28/2007 | US7262195 Compounds useful as motilin agonists and method |
| 08/28/2007 | US7262194 Therapeutic agents useful for treating pain |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | US7262192 Such as 1-(2-ethoxyethyl)-3-methyl-5-[(3R)-3-methylpiperazin-1-yl]-N-pyrimidin-4-yl-1H-pyrazolo[4,3-d]pyrimidin-7-amine; cyclic-guanosine monophosphate phosphodiesterase inhibitors |
| 08/28/2007 | US7262191 Benzothiadiazine compounds |
| 08/28/2007 | US7262190 Benzothiazine and benzothiadiazine compounds |
| 08/28/2007 | US7262189 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 08/28/2007 | US7262188 Phenyl sulfone derivatives and their use in the treatment of CNS disorders |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | US7262186 Kinesin spindle protein inhibitor; antiproliferative agents; anticancer agents; 4-(2,5-difluorophenyl0-N-3-fluoropyrrolidin-3-yl)-2-hydroxymethyl-2-phenyl-2,5-dihydro-1N-pyrrol-1-carboxamide |
| 08/28/2007 | US7262185 For therapy and prophylaxis of infectious diseases of HIV, in particular, AIDS and is also suitable for oral administration |